Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Viral Hepatitis|May 1, 2004
Epoetin alfa treatment for acute anaemia during interferon plus ribavirin combination therapy for chronic hepatitis CN Bräu
The Annals of Thoracic Surgery|September 1, 1992
Cardiac valve replacement in patients infected with the human immunodeficiency virusN Bräu, R A Esposito, M S Simberkoff
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1992
Tuberculous abscesses in patients with AIDSH Lupatkin, N Bräu, P Flomenberg, et al.
Cell and Tissue Kinetics|January 1, 1986
Influence of the beta-adrenergic antagonists propranolol, practolol and oxprenolol on the proliferation of rat jejunal crypt cellsB Maurer-Schultze, N Bräu, M Theiss, et al.
Alimentary Pharmacology & Therapeutics|May 7, 2009
Review article: adherence to medication for chronic hepatitis C - building on the model of human immunodeficiency virus antiretroviral adherence researchJ J Weiss, N Bräu, A Stivala, et al.
Journal of Viral Hepatitis|August 16, 2006
Decline in haemoglobin A1c values in diabetic patients receiving interferon-alpha and ribavirin for chronic hepatitis CP D Greenberg, A S Rosman, L S Eldeiry, et al.
Journal of Medical Virology|April 26, 2007
Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?M Rodríguez-Torres, J Gonzalez-Garcia, N Bräu, et al.
Alimentary Pharmacology & Therapeutics|October 17, 2017
The albumin-bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV-associated hepatocellular carcinomaD J Pinato, R Sharma, C Citti, et al.
Journal of Viral Hepatitis|April 14, 2006
Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin*N Bräu, E J Bini, S Currie, et al.
Pageof 1